DVx Inc. Reports Unaudited Non-Consolidated Financial Results for the Year Ended March 31, 2018; Provides Non-Consolidated Financial Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019
May 14, 2018
Share
DVx Inc. reported unaudited non-consolidated financial results for the year ended March 31, 2018. For the year, the company reported net sales of JPY 38,275 million against JPY 35,266 million a year ago. Operating profit was JPY 1,320 million against JPY 1,524 million a year ago. Ordinary profit was JPY 1,346 million against JPY 1,491 million a year ago. Profit was JPY 856 million against JPY 1,025 million a year ago. Earnings per share were JPY 75.92 against JPY 90.98 a year ago. Profit per equity share were 12.1% against 16.1% a year ago. Cash flows from operating activities was JPY 1,205 million against JPY 1,152 million a year ago.
The company provided non-consolidated financial guidance for the six months ending September 30, 2018 and full year ending March 31, 2019. For the six months, the company expects net sales of JPY 19,919 million, operating profit of JPY 572 million, ordinary profit of JPY 572 million, Profit of JPY 383 million and earnings per share of JPY 34.01.
For the full year, the company expects net sales of JPY 41,587 million, operating profit of JPY 1,346 million, ordinary profit of JPY 1,346 million, Profit of JPY 900 million and earnings per share of JPY 79.88.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Reports Unaudited Non-Consolidated Financial Results for the Year Ended March 31, 2018; Provides Non-Consolidated Financial Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019